Susan C. Low

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

Pharmacy, Pharmaceutics, Pharmacology +17

Knowing when not to stop: selenocysteine incorporation in eukaryotes

Susan C. Low, Marla J. Berry · Trends in Biochemical Sciences · 1996 · 433 citations

Life Sciences, Biochemistry, Molecular Biology +9

Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan et al. · Clinical Cancer Research · 2016 · 272 citations

Pharmacy, Oncology, Pharmacology +17

Design and testing of a humanized porcine donor for xenotransplantation

R. Anand, Jacob V. Layer, Dávid Héja et al. · Nature · 2023 · 264 citations · Full text

Life Sciences, Immunology, Nephrology +17

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

Alan J. Bitonti, Jennifer Dumont, Susan C. Low et al. · Proceedings of the National Academy of Sciences · 2004 · 229 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacokinetics +13